Premature Rupture of Membranes (PROM) Testing Market Analysis

Premature Rupture of Membranes (PROM) Testing Market Analysis

The premature rupture of membranes testing market by product type is segmented into nitrazine test, ferning test, pooling test, ultrasound, and others. The nitrazine test segment is predicted to witness CAGR of 5.7% during the forecast period. Continuous technological advancements and integration of digital solutions in nitrazine test to enhance accuracy, ease of use, and interpretation will foster segmental growth. Also, integration of digital solutions to enhance result interpretation and documentation by providing objective colour analysis, automate result interpretation, and enable seamless data integration with electronic medical records (EMRs). Moreover, several manufacturers are developing innovative Nitrazine test strips and swabs with improved sensitivity and specificity to gain more reliable and precise results.

The premature rupture of membranes testing market by end-use is categorized into hospitals, diagnostic laboratories and others. Diagnostic laboratories segment held largest revenue size accounting for over USD 2 billion in 2022 and is forecasted to dominate the regional market throughout the analysis period. The high segment growth is attributable to early diagnosis of PROM to avoid devastating and life-threatening maternal hazards. The growing recognition of the importance of early and accurate diagnosis of PROM leading to an increased demand for PROM testing.
 

Growing demand for diagnostic laboratories owing to upsurge in the number of samples for analysis, necessitating the need to scale up their testing capacity and optimize workflows to meet the growing demand. Moreover, the consideration of presently accessible widely recognized standard guidelines of PROM testing and the availability of skilled professionals among the settings is one of the major driving factors for the diagnostic laboratories segment in the PROM testing market.

U.S. premature rupture of membranes testing market accounted for USD 1 billion in 2022 and is anticipated to witness substantial industry growth over the projected period. Rising prevalence rate of preterm births across the nation is driving the PROM Testing market. For instance, Centers For Disease Control and Prevention, in United States, around 1 out of 10 infants associated with preterm birth in the year 2022.  Growing emphasis on improving neonatal outcomes, healthcare providers are increasingly recognizing the importance of PROM testing accelerating the demand for diagnostic services. Growing awareness about the importance of early detection and management of PROM is driving increased screening efforts. Public health initiatives, educational campaigns, and awareness programs conducted by healthcare organizations and government agencies creating a greater emphasis on PROM testing.